Which panels are worth running at each stage, what a result can and cannot tell you, and when more data makes things worse.
Sep 2026 · Four minutes.
A lab value is data. It is not a diagnosis, a treatment plan, or a complete picture of your health.
The strongest reason to order a test is that the result will change something — diagnosis, treatment, monitoring, or the need for further evaluation.
Many biomarkers vary with time of day, meals, hydration, exercise, acute illness, menstrual timing, medications, and laboratory method. A result near a cutoff should not automatically become a diagnosis. Trends and repeat testing are often more informative.
A reference interval describes values seen in a defined population. It is not automatically an optimal target, and it does not by itself define disease. Clinical thresholds for treatment come from outcome studies and professional guidelines, not from the printed range.
FSH and estradiol can change substantially across and between cycles, so one result may not represent the pattern. In women over forty-five with typical cycle changes and symptoms, the transition is often identified clinically rather than by testing.
Hormone testing becomes more useful when the presentation is atypical, when menopause may be premature, or when another endocrine disorder is suspected.
Perimenopause: estradiol, progesterone, testosterone and free testosterone, DHEA-S, morning cortisol, a full thyroid panel including antibodies, ferritin, vitamin D, hs-CRP, fasting insulin.
Menopause transition: estradiol, progesterone, FSH and LH, testosterone, DHEA-S, lipid panel, A1c and fasting insulin, hs-CRP, thyroid panel, vitamin D, CBC and ferritin.
Postmenopause: the above plus omega-3 index, ApoB and lipoprotein(a), bone markers such as P1NP and CTX, B12, and a CMP.
These are conversation starters for your clinician, not a shopping list.
Fatigue, hair changes, palpitations, low mood, brain fog, sleep disturbance, and reduced exercise tolerance overlap with thyroid disease, anemia or iron deficiency, B12 deficiency, glucose disorders, medication effects, and sleep apnea.
Heavy perimenopausal bleeding can deplete iron well before hemoglobin looks frankly low — which is why ferritin is worth asking about specifically.
Large wellness panels find incidental abnormalities and can create unnecessary repeat testing and real anxiety.
Prefer tests with a clear rationale, a validated method, and a plan for what you will do with the result.
What are we looking for? Could medications, supplements, illness, fasting status, or cycle timing alter the result? If it is abnormal, what decision changes? If it is normal, what possibilities remain?